CVS Health will allow self-funded insurers to exclude some drugs from coverage if the cost is too high. The policy has been met with criticism from the pharmaceutical industry, which argues CVS is dividing treatment at arbitrary values.

The International Contrast Ultrasound Society (ICUS) submitted a citizen petition to the FDA asking the agency to eliminate boxed warnings from ultrasound contrast agents (UCAs) because data and clinical experience show they are unnecessary.

The FDA has approved Contego Medical’s Paladain Carotid PTA Balloon System, the first approved embolic protection device to contain both a carotid angioplasty balloon and an integrated filter.

Using artificial intelligence, researchers at the NYU School of Medicine can correctly distinguish between two different types of lung tumors—adenocarcinoma and squamous cell carcinoma—with 97 percent accuracy.

According to a recent report by the Associated Press, therapists are increasingly taking advantage of virtual reality (VR) therapy to help patients get over their fears.

Patients with high-deductible health plans (HDHPs) continue to see out-of-pocket costs rise. Despite this, healthcare prices remain largely a mystery to consumers—but what if a hospital helped families better understand their potential out-of-pocket expenses?

DUBLIN — September 18, 2018 — Medtronic plc (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a single-arm study to evaluate the CoreValve Evolut(TM)TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality.

On Monday, Sept. 17, Indianapolis-based TriMedx announced plans to buy the healthcare technologies division of Aramark Corporation for $300 million. The two companies have signed a definitive agreement and expect the transaction to be completed by the end of the year.

NorthStar Medical Technologies, the Beloit, Wisconsin-based parent company of NorthStar Medical Radioisotopes, has appointed Stephen Merrick as president and CEO. Merrick was first hired in 2016 as the company’s senior vice president and chief operating officer.

CVS Health’s $69 billion takeover of Aetna may soon be greenlit by the U.S. Department of Justice Antitrust Division, according to Reuters, which cited a source familiar with the matter.